Show simple item record

dc.contributor.authorDyar, N
dc.contributor.authorMattick, K
dc.contributor.authorBethune, R
dc.date.accessioned2022-09-16T14:14:38Z
dc.date.issued2021-12-23
dc.date.updated2022-09-16T13:47:36Z
dc.description.abstractOBJECTIVES: Gentamicin is the aminoglycoside antibiotic of choice in the UK. It has a narrow therapeutic index: underdosing results in inefficacy while overdosing is characterised by nephrotoxicity and ototoxicity. To improve patient safety, hospitals have protocols for the prescription of gentamicin, which vary in complexity and approach. This study aimed to explore two distinct protocols for prescribing gentamicin in hospital settings, in order to understand the mechanisms they trigger and the outcomes they achieve. SETTING: A mixed-methods realist evaluation explored gentamicin prescribing protocols in two hospital surgical admissions units in South West England between January and August 2018. Site 1 had a traditional, complex protocol, while site 2 took a simplified protocol. PARTICIPANTS: Testing the initial programme theory (IPT) involved semi-structured audio-recorded interviews of a volunteer sample of healthcare professionals (HCPs) involved in the prescribing and administering process, alongside a clinical audit reviewing accuracy of gentamicin prescribing. OUTCOME MEASURES: Three sequential phases were used to identify factors in a successful protocol: IPT generation; testing; refinement of the IPT. The IPT was generated by literature search and analysis of existing protocols of sites 1 and 2. Refinement of the IPT synthesised the results of the quantitative and qualitative research to identify the key characteristics of a successful protocol. RESULTS: One hundred gentamicin prescriptions were reviewed, with a mean accuracy of gentamicin prescribing at site 1 of 65.67% and at site 2 of 78.79% (p<0.01). Thirty HCPs were interviewed. Key contexts were identified including prescriptiveness, experience and availability of patient information. These triggered hidden mechanisms including uncertainty, fear, confidence and frustration leading to both intended outcomes but also unintended outcomes such as deviation from protocol and unnecessary gentamicin levels. CONCLUSIONS: A simplified prescribing protocol for gentamicin is better accepted by prescribers, leading to better adherence to protocol and more accurate prescribing.en_GB
dc.format.extente052697-
dc.format.mediumElectronic
dc.identifier.citationVol. 11, no. 12, article e052697en_GB
dc.identifier.doihttps://doi.org/10.1136/bmjopen-2021-052697
dc.identifier.urihttp://hdl.handle.net/10871/130872
dc.identifierORCID: 0000-0003-1800-773X (Mattick, Karen)
dc.identifierScopusID: 56723888400 | 57130622400 | 6701773218 (Mattick, Karen)
dc.identifierORCID: 0000-0002-1855-0639 (Bethune, Rob)
dc.language.isoenen_GB
dc.publisherBMJen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/34949620en_GB
dc.rights© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.en_GB
dc.subjectclinical auditen_GB
dc.subjecteducation & training (see medical education & training)en_GB
dc.subjectmicrobiologyen_GB
dc.subjectprotocols & guidelinesen_GB
dc.subjectqualitative researchen_GB
dc.titleExploring two distinct gentamicin prescribing protocols in UK hospitals: a mixed-methods realist evaluation.en_GB
dc.typeArticleen_GB
dc.date.available2022-09-16T14:14:38Z
dc.identifier.issn2044-6055
exeter.article-numberARTN e052697
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available from BMJ Publishing via the DOI in this record. en_GB
dc.descriptionData availability statement: Data are available upon reasonable request. The raw data cannot be made freely available to share, given the nature of the consents given by participants. However, the corresponding author (ND ORCID ID: 0000-0002-8797-3467) can be contacted to discuss possible secondary analyses of deidentified participant data.en_GB
dc.identifier.journalBMJ Openen_GB
dc.relation.ispartofBMJ Open, 11(12)
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_GB
dcterms.dateAccepted2021-11-24
dc.rights.licenseCC BY-NC
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2021-12-23
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-09-16T14:12:36Z
refterms.versionFCDVoR
refterms.dateFOA2022-09-16T14:14:50Z
refterms.panelAen_GB
refterms.dateFirstOnline2021-12-23


Files in this item

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.